fda news - Search News

Trump, FDA

Click in for more news from The Hill{beacon} Health Care Health Care The Big Story Trump picks heads of CDC, FDA and surgeon general President-elect Trump has announced his

STAT · 1d

Trump’s pick to run FDA is top exec of company that provides compounded weight-loss drugs

Martin Makary, President-elect Trump’s pick for running the Food and Drug Administration, is an executive of the telehealth company Sesame, which connects consumers to physicians who can prescribe compounded weight-loss drugs.

The Washington Post on MSN · 2d

Trump picks Marty Makary to lead FDA, Dave Weldon to run CDC

Makary and Weldon, who have criticized the agencies they may soon run, were joined by Janette Nesheiwat, Trump’s pick to be surgeon general.

FDA, asthma

USA TODAY on MSN · 1d

YAHOO!News · 1d

"It's definitely doing something that's concerning," one scientist said about reported side effects of the drug.

Becker's Hospital Review · 5h

Asthma drug linked to severe mental health side effects: FDA

A new study on asthma medication Singulair has raised concerns about its potential mental health side effects, USA Today reported Nov. 24. The study, presented by the FDA at the American College of Toxicology meeting in Austin,

FDA, TTR and BridgeBio

Medpage Today on MSN · 21h

Acoramidis Snags FDA Approval for ATTR Cardiomyopathy

Acoramidis (Attruby) gained FDA approval for treating wild-type or variant transthyretin (TTR) amyloidosis cardiomyopathy (ATTR-CM), BridgeBio Pharma announced. Offering patients near-complete TTR stabilization in an oral tablet,

MarketWatch · 12h

BridgeBio Pharma Gets FDA Approval for Heart Disease Drug Attruby

The Palo Alto, California-based biopharmaceutical company said the Food and Drug Administration approved Attruby for adults with transthyretin amyloid cardiomyopathy, or ATTR-CM, to reduce cardiovascular death and cardiovascular-related hospitalization.

Yahoo · 16h

FDA approves BridgeBio’s Attruby for ATTR-CM treatment

Attruby is the first approved product with a label that specifies near-complete TTR stabilisation. The approval triggers a $500m payment to BridgeBio under a royalty funding agreement. The ATTRibute-CM Phase III trial,

FDA defeats lawsuit by lawyer vying to shield identity in inspection report

A judge has dismissed a lawsuit against the U.S. Food and Drug Administration by a lawyer who objected to being identified in ...

7hon MSN

Vivek Ramaswamy’s crusade to change FDA could boost biotech, and himself

The co-leader of President-elect Donald Trump’s initiative to cut government spending has a financial stake in the biotech ...

E&E8h

Trump’s FDA nom has harsh language for chemicals in food

If confirmed as FDA commissioner, Dr. Marty Makary would oversee testing on foods for pollutants like "forever chemicals" and ...

12h

Exclusive: Thousands turn to Wegovy copies each month as FDA considers shortage status

More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each ...

STAT1d

Trump’s FDA director pick has a history of criticizing the agency. Here are seven examples

WASHINGTON — Johns Hopkins surgeon Marty Makary has criticized – sometimes with harsh language – the Food and Drug ...

Allurion launches compounded GLP-1 program as FDA aims to ends access

Allurion's new program uses artificial intelligence guidance to help patients adhere to a well-rounded diet and exercise ...

Managed Healthcare Executive3h

FDA Approves New Imatinib Oral Formulation for Ten New Cancer Indications

Imkeldi is a new formulation of imatinib approved as a strawberry-flavored, shelf-stable liquid designed to be more appealing ...

3hon MSN

Hims & Hers Shares Jump as Trump FDA Pick Seen as Major Ally

Hims & Hers Health Inc. shares surged 24% to close at fresh record after Hunterbrook Media said the company is poised to be a ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Trump, FDA

FDA, asthma

FDA, TTR and BridgeBio

Related topics